Tizanidine Tablet
Product Images NDC 63187-145

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 63187-145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure- Tizanidine HCl (953db236 B848 484f 83b7 436c3a274c88 01)

Chemical structure of tizanidine hydrochloride showing a chlorinated benzene ring fused to a thiazole ring and an imidazoline ring.*

FDA Label Image

Figure 1 (953db236 B848 484f 83b7 436c3a274c88 02)

A line graph depicting mean plasma tizanidine concentrations (mg/mL) over time (hours from dosing) after taking 2 x 4 mg tizanidine tablets with food and without food. The graph shows plasma levels rising quickly to peak within 1-2 hours, then declining over 24 hours, comparing the effect of food on absorption.*

FDA Label Image

Figure 2 (953db236 B848 484f 83b7 436c3a274c88 03)

A line graph depicting the improvement in Ashworth Score over 6 hours post-dose for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The vertical axis measures improvement in Ashworth Score, while the horizontal axis shows hours post-dose. Data points include error bars indicating variability.*

FDA Label Image

Figure 3 (953db236 B848 484f 83b7 436c3a274c88 04)

A line graph comparing the improvement in Ashworth Score between tizanidine (mean dose 28.8 mg) and placebo over three time points: End of Titration (Week 3), End of Maintenance (Week 7), and Endpoint (Last Observation Carried Forward). The graph shows greater improvement with tizanidine compared to placebo at all time points.*

FDA Label Image

Tizanidine 4mg (953db236 B848 484f 83b7 436c3a274c88 05)

Label for tizanidine 4 mg tablets by Proficient Rx LP, containing 30 tablets. Each tablet has 4.576 mg tizanidine hydrochloride equivalent to 4 mg tizanidine base. The label includes product ID PT014530, storage instructions at 20°-25°C, and manufacturer Apotex Inc. Warnings note the tablets are not interchangeable with tizanidine capsules or Zanaflex capsules. The label also shows NDC 63187-145-30 and multiple lot and expiration placeholders.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.